莎普爱思：关于获得二氟尼柳片《药品补充申请批准通知书》的公告

Group 1 - The core point of the article is that the company, Shapais, has received approval from the National Medical Products Administration for the drug Diflunisal tablets, as indicated by the issuance of the Supplementary Application Approval Notice [2] Group 2 - The approval notice has the reference numbers 2026B00097 and 2026B00098, which are essential for tracking the regulatory process [2]